The program targets people who have received a vaccine through the COVAX platform, created by WHO and other entities to ensure equitable access to these treatments in middle- and low-income countries, reports EFE, quoted by Agerpres.
All vaccines distributed as part of this program have gone through their own stages of developing a vaccine that guarantees its effectiveness, safety and quality. However, all of these drugs, including vaccines that have been approved for general use, can rarely cause serious side effects, the WHO said in a statement.
More than 190 countries participate in COVAX. Of these, 92 low-income countries were selected to receive platform-funded vaccines. The compensation program announced on Monday only applies to these countries, the WHO said.
“This is the first and only compensation mechanism for vaccines caused by vaccines operating internationally,” the WHO said.
The aim is to provide this group of countries with a fast, fair and transparent procedure to receive compensation in cases of “rare and serious adverse effects associated with the distribution of COVAX vaccines by 30 June 2022”. In this way, the affected people will not have to resort to courts and initiate lawsuits that can be long and costly.
No cases of very serious side effects have been reported in the approximately 208 million doses of vaccine given in different countries.
On rare occasions, an adverse reaction has been observed in patients with a history of allergies, 4 or 5 cases per million people receiving the Pfizer vaccine, or 2-3 cases per million in Moderna vaccines, according to US statistics.
For this compensation program, WHO has entered into an agreement with the insurance company Chubb Limited.
If you like this article, we expect you to join the community of readers on our Facebook page, with a Like below:
#promises #people #suffered #severe #reactions #vaccines #receive #compensation
